Odyssey Raises $304M in Upsized IPO
May 11, 2026
Odyssey Therapeutics raised $304M in an upsized Nasdaq IPO to fund OD-001, SLC15A4 and TNFR2 autoimmune pipeline programs.
May 11, 2026
Odyssey Therapeutics raised $304M in an upsized Nasdaq IPO to fund OD-001, SLC15A4 and TNFR2 autoimmune pipeline programs.